Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-28

Clinical Trial Update: Effect of Tetrabenazine on Stroop Interference in HD [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of tetrabenazine on Stroop interference in Huntington disease has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tetrabenazine (tetrabenazine)

Snippet

Sponsor: New York Medical College | Conditions: Huntington Disease | Phase 4 | Status: COMPLETED | Results posted: 2025-05-28